Market Movers (8-K)
See all →NYSE
McCormick & Company announced the dismissal of Ernst & Young LLP as its independent auditor, effective upon the filing of its annual report, and the engagement of KPMG LLP.
NYSE
McCormick & Company announces the upcoming resignation of Board Director Anne Bramman, who also chairs the Audit Committee, due to her new executive role at Best Buy.
NYSE
McCormick & Company reported a 16.7% increase in second-quarter net sales and reaffirmed its full-year 2026 financial outlook.
Capital raise
NYSE
McCormick & Company, Inc. announced the appointment of Cindy Hoots, former Chief Digital Officer and CIO of AstraZeneca PLC, to its Board of Directors, effective June 1, 2026.
NYSE
McCormick & Company appoints Andrew Foust as Chief Integration Officer to lead the Unilever foods business combination.
NYSE
McCormick & Company has entered into a definitive agreement to acquire Unilever's global foods business in a transaction valued at $15.7 billion.
Capital raise
Quarterly Earnings (10-Q)
See all →NYSE
McCormick & Company reported 16.7% net sales growth in Q2 2026, driven by the consolidation of McCormick de Mexico and ongoing strategic integration efforts.
Capital raise
NYSE
McCormick & Company reports strong first-quarter sales growth driven by acquisitions and favorable pricing, while announcing a transformative merger with Unilever's Foods business.
Capital raise
Better than expected
NYSE
McCormick & Company reported a 2.7% increase in net sales for the third quarter of 2025, alongside a strategic acquisition to boost its ownership in McCormick de Mexico.
Capital raise
NYSE
McCormick & Company reported a 1.0% increase in net sales for the second quarter of 2025, reaching $1,659.5 million, alongside a 5.0% rise in operating income, despite a significant increase in special charges and a higher effective tax rate.
Worse than expected
NYSE
McCormick & Company's first quarter 2025 net sales edged up 0.2% year-over-year, with currency fluctuations impacting overall growth.
Worse than expected
NYSE
McCormick & Company's third-quarter results show a slight sales decrease but improved profit margins driven by cost-saving initiatives.
Better than expected
Annual Reports (10-K)
NYSE
McCormick & Company reported a 1.7% net sales increase in 2025, driven by volume and pricing, and projects 13-17% sales growth in 2026, significantly boosted by the McCormick de Mexico acquisition.
Capital raise
NYSE
McCormick & Company's fiscal year 2024 saw modest sales growth and improved operating income, but the company anticipates a slower growth trajectory in 2025 due to currency headwinds and strategic investments.
Worse than expected
NYSE
McCormick & Company's 2023 annual report reveals a 4.9% increase in net sales, primarily due to pricing actions, alongside strategic cost management and investments in future growth.
Insider Trading (Form 4)
See all →NYSE
Brendan M Foley, Chairman, President & CEO and a Director of Mccormick & Co Inc, received 51 shares of common stock on September 23, 2026.
NYSE
McCormick & Company outlines its strategic vision for global flavor leadership through the acquisition of Unilever Foods, detailing integration plans, synergy targets, and a strengthened financial outlook.
NYSE
McCormick & Company announces definitive agreement to acquire Unilever's global spreads business for $7 billion, aiming to expand its flavor portfolio and global reach.
Capital raise
NYSE
Andrew Foust, Chief Integration Officer of Mccormick & Co Inc, reported multiple transactions in common stock on July 20, 2026.
NYSE
Margaret M Preston V, a Director of Mccormick & Co Inc, reported a transaction in 269 shares of common stock on July 20, 2026.
NYSE
Sarah Piper, Chief Human Relations Officer of Mccormick & Co Inc, received 49 shares of common stock on September 8, 2026.
Proxy Statements (Def-14A)
NYSE
McCormick & Company, Incorporated has filed a definitive proxy statement with the SEC.
NYSE
McCormick & Company will hold its 2025 Annual Meeting virtually on March 26, 2025, and has released details on director nominees and executive compensation for fiscal year 2024.
Schedule 13D - Activist Investments
NYSE
Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, Inc., has amended his Schedule 13D filing to report transactions including the sale of 125,385 shares and the exercise and sale of 205,538 shares.
NYSE
SCHEDULE: McCormick CEO Foley Boosts Stake to 5.1%
McCormick & Company's Chairman, President, and CEO, Brendan M. Foley, reported beneficial ownership of 5.1% of the company's Common Stock, primarily through equity compensation.
NYSE
Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, reported an increased beneficial ownership of 11.8% of the company's common stock, including recent option exercises and sales.
NYSE
SCHEDULE 13D/A: Former McCormick & Company Executive Chairman Maintains Significant Stake, Updates Beneficial Ownership
Lawrence E. Kurzius, former Executive Chairman of McCormick & Company, Incorporated, has updated his beneficial ownership, reporting a 12.9% stake in the company's Common Stock.
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management has reported beneficial ownership of 19,099,707 shares, representing 7.53% of McCormick & Co Inc's common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.47% of McCormick & Co. Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group, Inc. has filed an amended Schedule 13G, reporting 0% beneficial ownership of McCormick & Co Inc/MD common stock following an internal corporate realignment.